626P Roginolisib (IOA-244), a first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) in patients with metastatic uveal melanoma.
Saved in:
| Title: | 626P Roginolisib (IOA-244), a first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) in patients with metastatic uveal melanoma. |
|---|---|
| Authors: | Di Giacomo, A.M.1 (AUTHOR), Simonelli, M.2 (AUTHOR), Santangelo, F.3 (AUTHOR), Amato, G.1 (AUTHOR), Simonetti, E.4 (AUTHOR), Graham, J.5 (AUTHOR), Lahn, M.6 (AUTHOR), Di Conza, G.7 (AUTHOR), Hammett, T.8 (AUTHOR), Zorrilla, R.8 (AUTHOR), Kaur, P.9 (AUTHOR), Ziyang, T.10 (AUTHOR), Lakshmikanth, T.10 (AUTHOR), Brodin, P.10 (AUTHOR), Occhipinti, M.11 (AUTHOR), Carlo-Stella, C.12 (AUTHOR), Santoro, A.13 (AUTHOR), Spiliopoulou, P.14 (AUTHOR), Evans, T.R.J.15 (AUTHOR), Maio, M.16 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS500-S500. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179692091 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 626P Roginolisib (IOA-244), a first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) in patients with metastatic uveal melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Di+Giacomo%2C+A%2EM%2E%22">Di Giacomo, A.M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Simonelli%2C+M%2E%22">Simonelli, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Santangelo%2C+F%2E%22">Santangelo, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amato%2C+G%2E%22">Amato, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Simonetti%2C+E%2E%22">Simonetti, E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Graham%2C+J%2E%22">Graham, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lahn%2C+M%2E%22">Lahn, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Conza%2C+G%2E%22">Di Conza, G.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hammett%2C+T%2E%22">Hammett, T.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zorrilla%2C+R%2E%22">Zorrilla, R.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaur%2C+P%2E%22">Kaur, P.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ziyang%2C+T%2E%22">Ziyang, T.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lakshmikanth%2C+T%2E%22">Lakshmikanth, T.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brodin%2C+P%2E%22">Brodin, P.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Occhipinti%2C+M%2E%22">Occhipinti, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carlo-Stella%2C+C%2E%22">Carlo-Stella, C.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Santoro%2C+A%2E%22">Santoro, A.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spiliopoulou%2C+P%2E%22">Spiliopoulou, P.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Evans%2C+T%2ER%2EJ%2E%22">Evans, T.R.J.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maio%2C+M%2E%22">Maio, M.</searchLink><relatesTo>16</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS500-S500. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692091 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.693 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S500 Titles: – TitleFull: 626P Roginolisib (IOA-244), a first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) in patients with metastatic uveal melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Di Giacomo, A.M. – PersonEntity: Name: NameFull: Simonelli, M. – PersonEntity: Name: NameFull: Santangelo, F. – PersonEntity: Name: NameFull: Amato, G. – PersonEntity: Name: NameFull: Simonetti, E. – PersonEntity: Name: NameFull: Graham, J. – PersonEntity: Name: NameFull: Lahn, M. – PersonEntity: Name: NameFull: Di Conza, G. – PersonEntity: Name: NameFull: Hammett, T. – PersonEntity: Name: NameFull: Zorrilla, R. – PersonEntity: Name: NameFull: Kaur, P. – PersonEntity: Name: NameFull: Ziyang, T. – PersonEntity: Name: NameFull: Lakshmikanth, T. – PersonEntity: Name: NameFull: Brodin, P. – PersonEntity: Name: NameFull: Occhipinti, M. – PersonEntity: Name: NameFull: Carlo-Stella, C. – PersonEntity: Name: NameFull: Santoro, A. – PersonEntity: Name: NameFull: Spiliopoulou, P. – PersonEntity: Name: NameFull: Evans, T.R.J. – PersonEntity: Name: NameFull: Maio, M. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
